USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$2.69B
Market Cap
27.92
P/E Ratio
0.26
EPS
$9.85
52 Week High
$4.25
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $6.8B |
Total Revenue | $9.6B |
Cost Of Revenue | $2.8B |
Costof Goods And Services Sold | $2.8B |
Operating Income | $1.5B |
Selling General And Administrative | $3.3B |
Research And Development | $616M |
Operating Expenses | $5.3B |
Investment Income Net | - |
Net Interest Income | -$1.4B |
Interest Income | $33M |
Interest Expense | $1.4B |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$9M |
Income Before Tax | $167M |
Income Tax Expense | $239M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$72M |
Comprehensive Income Net Of Tax | - |
Ebit | $1.6B |
Ebitda | $1.5B |
Net Income | -$46M |
Field | Value (USD) |
---|---|
Total Assets | $27B |
Total Current Assets | $5.8B |
Cash And Cash Equivalents At Carrying Value | $1.2B |
Cash And Short Term Investments | $1.2B |
Inventory | $1.6B |
Current Net Receivables | $2.1B |
Total Non Current Assets | $21B |
Property Plant Equipment | $2B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $5.6B |
Intangible Assets Excluding Goodwill | $5.6B |
Goodwill | $11B |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $858M |
Other Non Current Assets | - |
Total Liabilities | $27B |
Total Current Liabilities | $6.8B |
Current Accounts Payable | $656M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.7B |
Total Non Current Liabilities | $20B |
Capital Lease Obligations | - |
Long Term Debt | $19B |
Current Long Term Debt | $2.7B |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $22B |
Other Current Liabilities | $3.4B |
Other Non Current Liabilities | $1B |
Total Shareholder Equity | -$1.3B |
Treasury Stock | - |
Retained Earnings | -$9.8B |
Common Stock | $10B |
Common Stock Shares Outstanding | $368M |
Field | Value (USD) |
---|---|
Operating Cashflow | $1.6B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.3B |
Capital Expenditures | $337M |
Change In Receivables | - |
Change In Inventory | -$267M |
Profit Loss | - |
Cashflow From Investment | -$454M |
Cashflow From Financing | -$868M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$72M |
Field | Value (USD) |
---|---|
Gross Profit | $6.8B |
Total Revenue | $9.6B |
Cost Of Revenue | $2.8B |
Costof Goods And Services Sold | $2.8B |
Operating Income | $1.5B |
Selling General And Administrative | $3.3B |
Research And Development | $616M |
Operating Expenses | $5.3B |
Investment Income Net | - |
Net Interest Income | -$1.4B |
Interest Income | $33M |
Interest Expense | $1.4B |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$9M |
Income Before Tax | $167M |
Income Tax Expense | $239M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$72M |
Comprehensive Income Net Of Tax | - |
Ebit | $1.6B |
Ebitda | $1.5B |
Net Income | -$46M |
Field | Value |
---|---|
Ex Dividend Date | 2010-11-10 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 1.0 |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.